Pak J Biol Sci. 2022 Jan;25(4):304-312. doi: 10.3923/pjbs.2022.304.312.
<b>Background and Objective:</b> Synergistic combinations of antimicrobial agents with different mechanisms of action are successful approaches for combating bacterial infections. This study aimed to evaluate the synergistic effect of 1-methyl ester-nigericin <b>(1)</b> and methyl 5-(hydroxymethyl) furan-2-carboxylate <b>(2)</b> against <i>Proteus</i> spp., isolates. <b>Materials and Methods:</b> The synergistic antimicrobial activity of the compounds was tested by the checkerboard method and time-kill curves. To estimate the interaction between the compounds, the Fractional Inhibitory Concentration Index (FICI) of the combination was calculated. The cytotoxic activity of the compounds in combination was determined by the 3-(4,5-dimethylthiazol-2-yl)-2,5-diphenyl tetrazolium bromide (MTT) assay on LLC-MK2 cell lines. The reduction percentage of biofilms was obtained using the colourimetric method. <b>Results:</b> The MIC values for compounds <b>1</b> and <b>2</b> against test bacteria ranged from 39.06-78.12 μg mL<sup>1</sup> and from 78.12-156.25 μg mL<sup>1</sup>, respectively. The MIC was reduced to 1-8th as a result of the combination of compounds <b>1</b> and <b>2</b>. After 4-24 hrs of treatment with ½ MIC of compounds <b>1</b> and <b>2</b>, the killing rate (in CFU mL<sup>1</sup>) increased to a greater degree than observed with either test compound alone. The combination of compounds <b>1</b> and <b>2</b> showed a synergistic effect with FICI of 0.50 and 0.28. The synergistic combination of compounds <b>1</b> and <b>2</b> was effective on the biofilm reduction of <i>Proteus</i> <i>vulgaris</i> NP16 (85.72%) and NP47 (89.14%). <b>Conclusion:</b> This study recommends compounds <b>1</b> and <b>2</b> in combination as a potential alternative treatment agent for <i>Proteus</i> spp. infections.
具有不同作用机制的抗菌药物联合使用是对抗细菌感染的成功方法。本研究旨在评估 1-甲基酯-棉黄素(1)和 5-(羟甲基)呋喃-2-羧酸甲酯(2)对变形杆菌属分离株的协同作用。
采用棋盘法和时间杀伤曲线检测化合物的协同抗菌活性。通过计算化合物组合的部分抑菌浓度指数(FICI)来估计化合物之间的相互作用。通过 LLC-MK2 细胞系的 3-(4,5-二甲基噻唑-2-基)-2,5-二苯基四唑溴盐(MTT)测定化合物组合的细胞毒性。使用比色法测定生物膜减少百分比。
化合物 1 和 2 对测试细菌的 MIC 值分别为 39.06-78.12μg/mL 和 78.12-156.25μg/mL。化合物 1 和 2 联合使用后,MIC 降低至 1/8。在 1/2 MIC 的化合物 1 和 2 处理 4-24 小时后,与单独使用任何一种测试化合物相比,杀伤率(CFU/mL)增加了更大的幅度。化合物 1 和 2 的组合具有协同作用,FICI 为 0.50 和 0.28。化合物 1 和 2 的协同组合对普通变形杆菌 NP16(85.72%)和 NP47(89.14%)生物膜减少具有协同作用。
本研究推荐化合物 1 和 2 联合使用作为变形杆菌属感染的潜在替代治疗药物。